153 related articles for article (PubMed ID: 2859533)
21. Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.
Sharif NA; Wong EH; Loury DN; Stefanich E; Michel AD; Eglen RM; Whiting RL
Br J Pharmacol; 1991 Apr; 102(4):919-25. PubMed ID: 1830236
[TBL] [Abstract][Full Text] [Related]
22. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
Lyon RA; Davis KH; Titeler M
Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649
[TBL] [Abstract][Full Text] [Related]
23. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes.
Gozlan H; Thibault S; Laporte AM; Lima L; Hamon M
Eur J Pharmacol; 1995 Jan; 288(2):173-86. PubMed ID: 7720779
[TBL] [Abstract][Full Text] [Related]
24. Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding.
Hoyer D; Neijt HC
Mol Pharmacol; 1988 Mar; 33(3):303-9. PubMed ID: 3352595
[TBL] [Abstract][Full Text] [Related]
25. Circadian and seasonal rhythms of 5-HT receptor subtypes, membrane anisotropy and 5-HT release in hippocampus and cortex of the rat.
Weiner N; Clement HW; Gemsa D; Wesemann W
Neurochem Int; 1992 Jul; 21(1):7-14. PubMed ID: 1363861
[TBL] [Abstract][Full Text] [Related]
26. [3H]dihydroergotamine as a high-affinity, slowly dissociating radioligand for 5-HT1B binding sites in rat brain membranes: evidence for guanine nucleotide regulation of agonist affinity states.
Hamblin MW; Ariani K; Adriaenssens PI; Ciaranello RD
J Pharmacol Exp Ther; 1987 Dec; 243(3):989-1001. PubMed ID: 2826763
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the pharmacological characteristics of 5 HT1 and 5 HT2 binding sites with those of serotonin autoreceptors which modulate serotonin release.
Martin LL; Sanders-Bush E
Naunyn Schmiedebergs Arch Pharmacol; 1982 Dec; 321(3):165-70. PubMed ID: 7155196
[TBL] [Abstract][Full Text] [Related]
28. [3H]ICS 205-930 labels 5-HT3 recognition sites in membranes of cat and rabbit vagus nerve and superior cervical ganglion.
Hoyer D; Waeber C; Karpf A; Neijt H; Palacios JM
Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):396-402. PubMed ID: 2586633
[TBL] [Abstract][Full Text] [Related]
29. 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]ketanserin labeling of 5-hydroxytryptamine2 (5HT2) receptors in mammalian cells transfected with a rat 5HT2 cDNA: evidence for multiple states and not multiple 5HT2 receptor subtypes.
Teitler M; Leonhardt S; Weisberg EL; Hoffman BJ
Mol Pharmacol; 1990 Nov; 38(5):594-8. PubMed ID: 2233696
[TBL] [Abstract][Full Text] [Related]
30. Identification of serotonin receptors recognized by anti-idiotypic antibodies.
Tamir H; Liu KP; Hsiung SC; Yu PY; Kirchgessner AL; Gershon MD
J Neurochem; 1991 Sep; 57(3):930-42. PubMed ID: 1861158
[TBL] [Abstract][Full Text] [Related]
31. Characterization of [3H]quipazine binding to 5-hydroxytryptamine3 receptors in rat brain membranes.
Milburn CM; Peroutka SJ
J Neurochem; 1989 Jun; 52(6):1787-92. PubMed ID: 2566650
[TBL] [Abstract][Full Text] [Related]
32. Identification of binding sites for SR 46349B, a 5-hydroxytryptamine2 receptor antagonist, in rodent brain.
Rinaldi-Carmona M; Congy C; Pointeau P; Vidal H; Brelière JC; Le Fur G
Life Sci; 1994; 54(2):119-27. PubMed ID: 8277817
[TBL] [Abstract][Full Text] [Related]
33. Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain.
Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
Br J Pharmacol; 1990 Apr; 99(4):803-9. PubMed ID: 1972896
[TBL] [Abstract][Full Text] [Related]
34. Canine basilar artery contractions mediated by 5-hydroxytryptamine1A receptors.
Peroutka SJ; Huang S; Allen GS
J Pharmacol Exp Ther; 1986 Jun; 237(3):901-6. PubMed ID: 2940360
[TBL] [Abstract][Full Text] [Related]
35. [3H]WB4101 labels the 5-HT1A serotonin receptor subtype in rat brain. Guanine nucleotide and divalent cation sensitivity.
Norman AB; Battaglia G; Creese I
Mol Pharmacol; 1985 Dec; 28(6):487-94. PubMed ID: 2867462
[TBL] [Abstract][Full Text] [Related]
36. Identification and characterisation of 5-hydroxytryptamine 3 recognition sites in human brain tissue.
Barnes JM; Barnes NM; Costall B; Ironside JW; Naylor RJ
J Neurochem; 1989 Dec; 53(6):1787-93. PubMed ID: 2809591
[TBL] [Abstract][Full Text] [Related]
37. Neurophysiological effects of buspirone and isapirone in the hippocampus: comparison with 5-hydroxytryptamine.
Rowan MJ; Anwyl R
Eur J Pharmacol; 1986 Dec; 132(1):93-6. PubMed ID: 2880731
[TBL] [Abstract][Full Text] [Related]
38. [3H]BIMU-1, a 5-hydroxytryptamine3 receptor ligand in NG-108 cells, selectively labels sigma-2 binding sites in guinea pig hippocampus.
Bonhaus DW; Loury DN; Jakeman LB; To Z; DeSouza A; Eglen RM; Wong EH
J Pharmacol Exp Ther; 1993 Nov; 267(2):961-70. PubMed ID: 8246171
[TBL] [Abstract][Full Text] [Related]
39. Differential inactivation and G protein reconstitution of subtypes of [3H]5-hydroxytryptamine binding sites in brain.
Stratford CA; Tan GL; Hamblin MW; Ciaranello RD
Mol Pharmacol; 1988 Oct; 34(4):527-36. PubMed ID: 3139989
[TBL] [Abstract][Full Text] [Related]
40. [3H]zacopride: ligand for the identification of 5-HT3 recognition sites.
Barnes NM; Costall B; Naylor RJ
J Pharm Pharmacol; 1988 Aug; 40(8):548-51. PubMed ID: 2907008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
